Alzheimer Disease Clinical Trials Database - Free Access to 673 Studies
Access comprehensive clinical trial information for Alzheimer Disease through Pure Global AI's free database. This collection includes 673 clinical trials across multiple phases including N/A, Phase 1, Phase 2. Currently, 164 trials are actively recruiting participants.
Research for Alzheimer Disease is being conducted in United States of America, France, China and 7+ other countries. Leading sponsors include Wyeth is now a wholly owned subsidiary of Pfizer and Pfizer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Single Dose Escalation Study of CM383 in Healthy Volunteers
A Phase 1 Trial to Assess Safety, Tolerability and Pharmacokinetics of ALIA-1758 in Healthy Participants
Positron Emission Tomography Study in Healthy Subjects to Determine the Relationship Between Plasma Concentration and Brain Target Occupancy of ASN51
Systemic and Central Inflammation in AD
The Effect of Community Intervention on Different Degrees of Dementia
A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease: Implementation Phase 2
Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease
Next-Generation alzheImer'S Therapeutics
A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People
Effect of Acupuncture on the Gait Disturbance and Hemodynamic Changes in the Prefrontal Cortex
A Single Dose Escalation Study of HHT201 in Healthy Subjects
Indian Transforming Alzheimer's Care Training (INTACT)
A Study to Evaluate Efficacy and Safety of Intravenous ACU193 in Participants With Early Alzheimer's Disease (ALTITUDE-AD)
Intermittent Oral Tube in Alzheimer's Patients
German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation
Oral Enteral Nutrition Feeding in Alzheimer's Patients
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Feasibility of Lecanemab Registry and Clinical Outcome Measures
A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01
Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain)
Pure Global AI provides free access to 673 clinical trials studying Alzheimer Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Wyeth is now a wholly owned subsidiary of Pfizer, Pfizer, National Institute on Aging (NIA), among others.